Abstract
Single chain fragment (ScFv) antiidiotypic antibodies (antilds) of a killer toxin (KT) from the yeast Pichia anomala have been produced by recombinant DNA methodology from the splenic lymphocytes of mice immunized by idiotypic vaccination with a KT-neutralizing monoclonal antibody (Mab KT4). ScFv KT-like antilds (KTIdAb) react with specific Candida albicans KT cell wall receptors (KTR) exerting a can-didacidal activity in vitro could be neutralized by adsorption with Mab KT4. ScFv KTIdAb displayed an effective therapeutic activity in an experimental model of rat candidal vaginitis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jerne, N.K. 1974. Towards a network theory of the immune system. Ann. Immunol. Inst. Pasteur 125C: 373–389.
Poljak, R.J. 1994. An idiotope-anti-idiotope complex and the structural basis of molecular mimicking. Prac. Natl. Acad. Sci. USA 91: 1599–1600.
Gaulton, G.N. and Greene, M.I. 1986. Idiotypic mimicry of biological receptors. Annu. Rev. Immunol. 4: 253–280.
Nisonoff, A. and Gorish, M.F. 1984. From network theory toward vaccination by monoclonal antibodies, pp. 119–128 in New Horizons in Microbiology. Sanna, A. and Morace, G. (eds.). Elsevier Science Publishers, Amsterdam.
Brinkmann, U. and Pastan, I. 1994. Immunotoxins against cancer. Biochim. Biophys. Acta 1198: 27–45.
Bona, C. and Köhler, H. 1984. Antiidiotypic antibodies and internal images. Recept Biochem. Methodol. 14: 141–149.
Monroe, J.G. and Greene, M.I. 1986. Antiidiotypic antibodies and disease. Immunol. Invest. 15: 263–286.
Armstrong, D. 1993. History of opportunistic infections in the immunocompromised host. Clin. Infect. Dis. 17: 3318–3321.
Polonelli, L. and Morace, G. 1987. Production and characterization of yeast killer toxin monoclonal antibodies. J. Clin. Microbiol. 25: 460–462.
Polonelli, L and Morace, G 1986. Reevaluation of the yeast killer phenomenon. J. Clin. Microbiol. 24: 866–869.
Aliouat, E.M., Cailliez, J.C., Séguy, N., Dei-Gas, E., Polonelli, L. et al. 1993. Inhibitory effect of a yeast killer toxin to the in vitro Pneumocystis carinii attachment. Serodiagn. Immunother. Infect. Dis. 5: 102–106.
Polonelli, L. and Morace, G. 1988. Yeast killer toxin-like antiidiotypic antibodies. J. Clin. Microbiol. 26: 602–604.
Polonelli, L., Conti, S., Gerloni, M., Magliani, W., Castagnola, M., Morace, G. and Chezzi, C. 1991. “Antibiobodies”: antibiotic-like antiidiotypic antibodies. J. Med. Vet. Mycol. 29: 235–242
Polonelli, L., Lorenzini, R., De Bernardis, F., Gerloni, M., Conti, S., Morace, G., Magliani, W. and Chezzi, C. 1993. Idiotypic vaccination: Immunoprotection mediated by antiidiotypic antibodies with antibiotic activity Scand. J. Immunol. 37: 105–110
Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Gerloni, M., Morace, G., Magliani, W., Chezzi, C. and Cassone, A. 1994. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like antiidiotypic antibodies. J. Immunol. 152: 3175–3182.
Polonelli, L., Fanti, F., Conti, S., Campani, L., Gerloni, M., Castagnola, M., Morace, G. and Chezzi, C. 1990. Detection by immunofluorescent antiidiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. J. Immunol. Methods 132: 205–209.
Polonelli, L., De Bernardis, F., Conti, S., Boccanera, M., Magliani, W., Gerloni, M., Cantelli, C. and Cassone, A. 1996. Human natural yeast killer toxin-like candidacidal antibodies. J. Immunol. 156: 1880–1885.
Barbas, C.F., Kang, A.S., Lerner, R.A. and Benkovic, S.J. 1991. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc. Natl. Acad. Sci. USA 88: 7978–7982.
Clackson, T., Hoogenboom, H.R., Griffiths, A.D. and Winter, G. 1991. Making antibody fragments using phage display libraries. Nature 352: 624–628.
Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D. and Winter, G. 1991. By-passing immunisation: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222: 581–597.
McCafferty, J., Griffiths, A.D., Winter, G. and Chiswell, D.J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature (London) 348: 552–554.
Polonelli, L., Séguy, N., Conti, S., Gerloni, M., Bertolotti, D., Cantelli, C., Magliani, W. and Cailliez, J.C. Monoclonal yeast killer toxin-like candidacidal antiidiotypic antibodies. Clin. Diagn. Lab. Immunol., in press.
Cassone, A., Conti, S., De Bernardis, F. and Polonelli, L. Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol. Today, in press.
Cutler, J.E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45: 187–218.
Cassone, A., Boccanera, M., Adriani, D., Santoni, G. and De Bernardis, F. 1995. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun. 63: 2619–2624.
Fidel, P.L., Lynch, M.E. and Sobel, J.D. 1993. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect. Immun. 61: 1990–1995.
De Bernardis, F., Agatensi, L., Ross, I.K., Emerson, G.W., Lorenzini, R., Sullivan, P.A. and Cassone, A. 1990. Evidence for a role of secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161: 1276–1283.
Teti, G., Calapai, M., Calogero, G., Tomasello, F., Mancuso, G., Galli, A. and Riggio, G. 1992. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B Streptococci. Hybridoma 11: 13–22.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Magliani, W., Conti, S., Bernardis, F. et al. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol 15, 155–158 (1997). https://doi.org/10.1038/nbt0297-155
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0297-155
This article is cited by
-
A new humanized antibody is effective against pathogenic fungi in vitro
Scientific Reports (2021)
-
The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo
Scientific Reports (2020)
-
Recapitulation of the anti-Idiotype antibodies as vaccine candidate
Translational Medicine Communications (2018)
-
Immune defence against Candida fungal infections
Nature Reviews Immunology (2015)
-
The protective role of immunoglobulins in fungal infections and inflammation
Seminars in Immunopathology (2015)